ACVIM Veterinary Oncology Specialty Exam Practice Test
Gana confianza para ACVIM Veterinary Oncology Specialty Exam. Practica los conceptos, comprende las respuestas y refuerza tus conocimientos pregunta a pregunta.
Probar una preguntaDescripción y detalles del examen
The ACVIM Veterinary Oncology Specialty Exam is the definitive certification for veterinary professionals seeking board certification in veterinary oncology. Administered by the American College of Veterinary Internal Medicine (ACVIM), this rigorous examination validates a candidate's mastery of the diagnosis, staging, and multimodal management of cancer in companion animals and other species. Achieving Diplomate status signifies the highest level of expertise in the field, encompassing advanced knowledge of tumor biology, pathology, medical, surgical, and radiation oncology principles, and the ethical considerations of palliative and end-of-life care. Certification is the culmination of an intensive residency program and demonstrates a commitment to evidence-based medicine, continuing education, and advancing the standard of care in veterinary oncology. It distinguishes the holder as a specialist recognized by peers, referral veterinarians, and pet owners alike, establishing them as an authoritative resource in a complex and rapidly evolving discipline.
Preguntas de Muestra
Elige una respuesta y consulta la explicación para ver cómo funciona la práctica.
Which drug is a neurotoxic vinca alkaloid commonly used in CHOP protocols?
Vincristina es el alcaloide de vinca en CHOP y puede causar neurotoxicidad e ileo. El carboplatino es un agente de platino, no un vinca.
A clinician samples a 3 cm soft tissue mass with FNA and gets only blood. The mass is still growing. Which next diagnostic step is most appropriate?
Un FNA no diagnóstico no debe terminar la evaluación de un tumor creciente; el planificación de la biopsia debe preservar las márgenes futuras. El distractor benigno-lipoma es común cuando la citología es poco fructífera.
A dog with measurable nonresectable MCT is started on toceranib. The owner reports lameness, diarrhea, and anorexia after two weeks. What is the best response?
A high-grade MCT was incompletely excised from the distal limb, and wider surgery would be morbid. No gross disease remains. Which adjuvant local therapy is most appropriate to discuss?
A dog is hospitalized 7 days after carboplatin with fever, neutrophils 400/uL, and no localizing signs. Which management is most appropriate?
La neutropenia febril es una emergencia que requiere antibióticos y monitoreo. El distractor de la neutropenia esperada ignora el riesgo de fiebre y sepsis.
Qué temas cubre este examen
Usa las ponderaciones publicadas de los dominios para planificar tu estudio. Los resultados de práctica no predicen tu puntuación en el examen de certificación.
01Cancer Treatment Modalities
This domain covers various cancer treatment modalities, including surgery, chemotherapy, radiation therapy, and immunotherapy, emphasizing their application in veterinary clinical practice, which accounts for 25.0 percent of the total exam score.
02Tumor Behavior, Diagnostics & Prognostic Indicators
This domain focuses on the behavior of tumors, diagnostic techniques, and the identification of prognostic indicators to guide clinical decision-making for oncology patients, comprising 25.0 percent of the total examination weight.
03Principles of Cancer Biology
This domain covers the fundamental biological processes of cancer, focusing on cellular and molecular mechanisms that drive tumor development and progression in veterinary patients, accounting for 22.0 percent of the total exam content.
04Management of Oncology Patients
This domain addresses the clinical management of oncology patients, focusing on supportive care, monitoring, and the overall approach to treating animals with neoplastic disease, representing 18.0 percent of the exam.
05Research Principles
This domain addresses the application of research principles, including clinical trial design, biostatistics, and the evaluation of scientific literature within the field of oncology, representing 10.0 percent of the total exam content.